Hiroko Kimura
Overview
Explore the profile of Hiroko Kimura including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
79
Citations
448
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Kimura H, Mizuno K, Shiota M, Narita S, Terada N, Fujimoto N, et al.
Br J Cancer
. 2022 Aug;
127(9):1680-1690.
PMID: 35986085
Background: The prognostic significance of germline variants in homologous recombination repair genes in advanced prostate cancer (PCa), especially with regard to hormonal therapy, remains controversial. Methods: Germline DNA from 549...
12.
Nagano Y, Iwai T, Tomita M, Kimura H, Kosoku A, Kabei K, et al.
Exp Clin Transplant
. 2022 Jul;
20(6):630-632.
PMID: 35791835
No abstract available.
13.
Hara M, Hyodo A, Kimura H, Hiraki T
J Cardiothorac Vasc Anesth
. 2022 Jun;
36(9):3655-3661.
PMID: 35659830
No abstract available.
14.
Kimura H
Nihon Koshu Eisei Zasshi
. 2022 Apr;
69(6):424-434.
PMID: 35400723
Objectives The purpose of this study was to clarify the issues behind the increasing number of solitary deaths of older people in central Tokyo.Methods In this study a request was...
15.
Akamatsu S, Terada N, Takata R, Kinoshita H, Shimatani K, Momozawa Y, et al.
JNCI Cancer Spectr
. 2022 Feb;
6(1).
PMID: 35118230
Background: Multiple common variants and also rare variants in monogenic risk genes such as and have been reported to be associated with risk of prostate cancer (PCa); however, the clinical...
16.
Mizuno K, Sumiyoshi T, Okegawa T, Terada N, Ishitoya S, Miyazaki Y, et al.
Clin Cancer Res
. 2021 Sep;
27(22):6164-6173.
PMID: 34526361
Purpose: Although cell-free DNA (cfDNA) testing is expected to drive cancer precision medicine, little is known about the significance of detecting low-frequency variants in circulating cell-free tumor DNA (ctDNA) in...
17.
Li X, Nakayama K, Goto T, Kimura H, Akamatsu S, Hayashi Y, et al.
Cancer Sci
. 2021 Jul;
112(10):4292-4302.
PMID: 34328656
The altered levels of phospholipids (PLs) and lysophospholipids (LPLs) in prostate cancer (CaP) and benign tissues in our previous findings prompted us to explore PLs and LPLs as potential biomarkers...
18.
Kato D, Mori S, Harada E, Shigemori R, Shibazaki T, Matsudaira H, et al.
Case Rep Pulmonol
. 2021 Jul;
2021:5573869.
PMID: 34258099
. Intimal sarcoma is a very rare tumor arising within the intima of the pulmonary artery. Preoperative diagnosis of pulmonary artery sarcoma is difficult, and the tumor is sometimes misdiagnosed...
19.
Okasho K, Mizuno K, Fukui T, Lin Y, Kamiyama Y, Sunada T, et al.
Cancer Sci
. 2021 May;
112(7):2781-2791.
PMID: 33960594
The prevalence of neuroendocrine prostate cancer (NEPC) arising from adenocarcinoma (AC) upon potent androgen receptor (AR) pathway inhibition is increasing. Deeper understanding of NEPC biology and development of novel therapeutic...
20.
Kimura H, Uemura Y, Megumi Y, Fukuzawa S
Hinyokika Kiyo
. 2020 Dec;
66(10):337-342.
PMID: 33271646
Radical prostatectomy is one of the major treatment options for patients with localized prostate cancer, and biochemical recurrence (BCR) after surgery is regarded as one of the representative indicators of...